Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Raises $8M in Series B Funding

NEW YORK, Jan. 18 (GenomeWeb News) - Metabolon closed an $8 million Series B funding round, the company said today.


Investors in this round included Sevin Rosen Funds, Aurora Funds, and Trelys Funds. Harris & Harris Group participated as a new investor, contributing $2.5 million.


Metabolon, based in Research Triangle Park, NC, uses metabolomics to discover biomarkers. The company has ongoing biomarker-discovery collaborations with the National Cancer Institute, the Amyotrophic Lateral Sclerosis Association, and the US Centers for Disease Control and Prevention, among others.


The company raised $9 million in Series A funding in October 2004.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.